Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Burkitt Lymphoma 7Leukemia, Biphenotypic, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Hematologic Neoplasms 2Prostatic Neoplasms 1Pneumonia 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatectomy 1Drug-Related Side Effects and Adverse Reactions 1Down Syndrome 1Brain Neoplasms 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1Acute Gout 1

Interventions

trastuzumab deruxtecan 1sacituzumab govitecan 1Temozolomide 1Social Determinants of Health 1Methylprednisolone 1Irinotecan 1Cefixime 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Methylprednisolone × 90 days × Clear all
NCT07554885 2026-05-26

Nutritional + Usual Corticosteroids Randomized Trial for Immune-Related pneumoniA - Therapeutic Utilization Evaluation

Guangzhou Institute of Respiratory Disease

Phase NA Not yet recruiting
60 enrolled

Neoplasms, Pneumonia, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡